Tag Archives: biotechnology

DNA As Information. “Synthetic Genome” Paper Brings New Life To Old Debate

Posted on June 10, 2010 by Warren Woessner

In the landmark paper by Gibson, Smith, Venter et al, Science Express (May 20, 2010), reporting the successful replacement of one bacterial genome by a completely synthetic, functional chromosome,  the authors note: “This work provides a proof of principle for … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | Leave a comment

VENTER GROUP LABELS SYNTHETIC LIFE “PAT. PENDING”

Posted on June 7, 2010 by Warren Woessner

In the May 20th issue of Science Express, a group led by Daniel Gibson, Hamilton Smith and  J. Craig Venter published an article that got the full attention of scientists, bioethicists and IP attorneys worldwide: “Creation of a Bacterial Cell … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , | Leave a comment

Therasense To Be Re-Heard En Banc – “I Feel Your Pain”

Posted on April 28, 2010 by Warren Woessner

Monday’s decision by the Federal Circuit to vacate the split panel decision in Therasense, Inc. v. Becton Dickinson & Co., 593 F.3d 1289 (Fed. Cir. 2010) (link at end of post) and rehear the case en banc makes it impossible for … Continue reading →

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , , , , | Leave a comment

Stem Cell Patents Webinar and BIO Int’l Convention Symposium

Posted on April 19, 2010 by Warren Woessner

Patent Claims Coverage Webinar: Stem Cell Industry – Osiris Therapeutics – Amgen’s EPO – Wed., April 28, 12:00PM – 12:50PM CDT Sunlight Research™ invites you to attend a Stem Cell Industry Patent Claims Coverage webinar presented by Robin A. Chadwick, … Continue reading →

Posted in Conferences and Classes, Stem Cells/Cloning | Tagged , , , , , , , | Leave a comment